Clinical Trials in Houston

Showing 2061-2080 of 8,625 trials

Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

NCT05881252

The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is \>= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of \>= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (\>= 180 SBP).

Maternal Hypertension

The University of Texas Health Science Center, Houston1,003 participantsStarted May 2023

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

NCT05443724

The primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.

Schizophrenia

AbbVie700 participantsStarted Sep 2022

Phoenix, Arizona, United States • Bryant, Arkansas, United States • Little Rock, Arkansas, United States +82 more locations

Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

Find Trials by Condition in Houston

Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer

Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

Cooking HEalthy and Facilitating Early Childhood Development: CHEF-ED Study

QTX3046 in Patients With KRAS G12D Mutations

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Metabolic Effects of Fructose Intake

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Non-surgical Spinal Decompression Therapy and Outcomes

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)